Answers are grounded in this paper and cite their sources.
Diabetic kidney disease (DKD) is characterized by chronic metabolic and inflammatory stress and is clinically associated with complicated urinary infection. However, the renal programs that are reproducibly altered in DKD and uropathogenic Escherichia coli (UPEC) pyelonephritis remain incompletely defined. We reanalyzed murine snRNA-seq datasets (GSE184652 for DKD; GSE296327 for UPEC). Differential expression was tested via proximal-tubule (PT) pseudobulk analysis. Inflammation was evaluated using Hallmark/KEGG enrichment. Lpl function was validated in DKD-PT cells via overexpression assays (CCK-8, qRT-PCR, ELISA). UPEC showed positive inflammation-union enrichment in all seven eligible renal compartments, whereas DKD showed five selective, bidirectional compartment-direction signals. In PT, UPEC positively enriched all six inflammatory Hallmarks while DKD negatively enriched interferon-gamma and interferon-alpha responses. Seven genes were cohort-wise significant and direction-concordant. Lpl was downregulated in DKD and UPEC, localized descriptively to PT nuclei, and belonged to PPAR, cholesterol and glycerolipid metabolism pathways. Nevertheless, the minimum directional gene-level conjunction q was 0.133, WGCNA quality targets were not achieved. Functionally, LPL-1 overexpression significantly inhibited cell proliferation in both uPTECs and DKD-PTECs. Furthermore, LPL-1 overexpression markedly suppressed the transcriptional levels and protein secretion of key inflammatory cytokines, including TNF-α, IL-1β, and IL-6, in both cell types. DKD and UPEC exhibit divergent renal inflammatory programs. Lpl links tubular lipid handling to inflammation and may protect against DKD-associated tubular injury, warranting further validation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: